CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.010
-0.090 (-4.29%)
At close: Dec 5, 2025, 4:00 PM EST
2.050
+0.040 (1.99%)
After-hours: Dec 5, 2025, 5:55 PM EST
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$43,421
Profits / Employee
-$213,333
Market Cap
25.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 2 | 2.74% |
| Dec 31, 2022 | 73 | 7 | 10.61% |
| Dec 31, 2021 | 66 | 14 | 26.92% |
| Dec 31, 2020 | 52 | 14 | 36.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLGN News
- 10 days ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 18 days ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS - PRNewsWire
- 5 weeks ago - CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada - PRNewsWire
- 6 weeks ago - CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology - PRNewsWire
- 7 weeks ago - First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - PRNewsWire
- 2 months ago - CollPlant Expands the Distribution of its VergenixSTR Product in Europe - PRNewsWire
- 3 months ago - CollPlant to Present at the 2025 International Conference on Biofabrication - PRNewsWire